Brazg R, Xu L, Dalla Man C, Cobelli C, Thomas K, Stein PP. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
Diabetes Obes Metab. 2007;9(2):186-193.
Cornier MA, Dabelea D, Hernandez TL, et al. The metabolic syndrome.
Despres JP, Golay A, Sjöström L, Rimonabant in Obesity-Lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.
N Engl J Med. 2005;353(20):2121-2134.
Diabetes mellitus type 2 in adults. EBSCO DynaMed Plus website. Available at:
http://www.dynamed.com/topics/dmp~AN~T113993/Diabetes-mellitus-type-2-in-adults. Updated August 29, 2016. Accessed September 23, 2016.
Freemark M. Pharmacotherapy of childhood obesity.
Diabetes Care. 2007;30(2):395-402.
How is metabolic syndrome treated? National Heart, Lung, and Blood Institute website. Available at:
http://www.nhlbi.nih.gov/health/health-topics/topics/ms/treatment. Updated November 3, 2011. Accessed May 10, 2013.
Hypertension. EBSCO DynaMed Plus website. Available at:
http://www.dynamed.com/topics/dmp~AN~T115345/Hypertension. Updated June 26, 2014. Accessed September 30, 2014.
Hypertriglyceridemia. EBSCO DynaMed Plus website. Available at:
http://www.dynamed.com/topics/dmp~AN~T115419/Hypertriglyceridemia. Updated July 6, 2016. Accessed September 23, 2016.
Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity.
Ann Intern Med. 2005;142(7):532-546.
Medication. American Diabetes Association website. Available at:
http://www.diabetes.org/living-with-diabetes/treatment-and-care/medication. Accessed May 10, 2013.
Metabolic syndrome in adults. EBSCO DynaMed Plus website. Available at:
http://www.dynamed.com/topics/dmp~AN~T113812/Metabolic-syndrome-in-adults. Updated March 11, 2016. Accessed September 23, 2016.
Orchar TJ, Temprosa M, Goldberg R, et al. The effect of diet and exercise or metformin on the metabolic syndrome: The diabetes prevention program randomized trial.
Ann Intern Med.
Rosenstock J, Fitchet M. Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes.
Int J Clin Pract Suppl. 2008;(159):15-23.
Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia.
Expert Opin Pharmacother. 2008;9(7):1237-1248.
Steinberger J, Daniels SR, Eckel RH, et al. AHA scientific statement: progress and challenges in metabolic syndrome in children and adolescents.
Types of blood pressure medications. American Heart Association website. Available at:
http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/PreventionTreatmentofHighBloodPressure/Types-of-Blood-Pressure-Medications%5FUCM%5F303247%5FArticle.jsp#.V1bVtk2FMdU. Updated August 14, 2012. Accessed May 10, 2013.